Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Real-World Use, Effectiveness and Safety of Romiplostim, Eltrombopag and Avatrombopag in Immune Thrombocytopenia: Data from the Norwegian ITP Registry

Riccardo Tomasello, Lamya Garabet, Heidi Pettersen, Eirik Tjønnfjord, Galina Tsykunova, Torkild Pedersen, Hoa Tran, Mariasanta Napolitano, Waleed Ghanima

Blood (2023) 142 (Supplement 1): 3952.

https://doi.org/10.1182/blood-2023-182848

Published: 2023

Journal Articles

Validation of Differentially Expressed Micrornas in Primary Immune Thrombocytopenia Suggests Mir-199a-5p Is a Potential Diagnostic Biomarker

Lamya Garabet, Anbjørg Rangberg, Raul Teruel-Montoya, Maria Luisa Lozano, Christine Monceyron Jonassen, Waleed Ghanima

Blood (2023) 142 (Supplement 1): 2579.

https://doi.org/10.1182/blood-2023-184882

Published: 2023

Journal Articles

Health Related Quality of Life in Patients with Primary ITP Compared with Population Norms: A Multicenter Retrospective Analysis of Data from Norwegian ITP Registry

Riccardo Tomasello, Lamya Garabet, Heidi Pettersen, Hoa Tran, Mazdac Tavoly, Galina Tsykunova, Eirik Tjønnfjord, Mariasanta Napolitano, Waleed Ghanima

Blood (2023) 142 (Supplement 1): 3754.

https://doi.org/10.1182/blood-2023-188445

Published: 2023

Journal Articles

The Risk of Thromboembolism Associated with Treatment of ITP with Rituximab: Adverse Event Reported in Two Randomized Controlled Trials

Lamya Garabet, Pal André Holme, PhDMD, Bernadette Darne, Abderrahim Khelif, Tor Henrik Anderson Tvedt, MD, Marc Michel, Waleed Ghanima, MD PhD

Blood (2019) 134 (Supplement_1): 4892.

https://doi.org/10.1182/blood-2019-126974

Published: 2019

Journal Articles

Thrombin-Generating Capacity of Microvesicles (MVs) in Patients with Immune Thrombocytopenia (ITP) before and during Treatment with Thrombopoietin-Receptor Agonists (TPO-RA)

Lamya Garabet, Waleed Ghanima, MD PhD, Marit Hellum, Per Morten Sandset, James B. Bussel, MD, Carola E. Henriksson

Blood (2018) 132 (Supplement 1): 2511.

https://doi.org/10.1182/blood-2018-99-116911

Published: 2018

NARROW

Real-World Use, Effectiveness and Safety of Romiplostim, Eltrombopag and Avatrombopag in Immune Thrombocytopenia: Data from the Norwegian ITP Registry

Validation of Differentially Expressed Micrornas in Primary Immune Thrombocytopenia Suggests Mir-199a-5p Is a Potential Diagnostic Biomarker

Health Related Quality of Life in Patients with Primary ITP Compared with Population Norms: A Multicenter Retrospective Analysis of Data from Norwegian ITP Registry

The Risk of Thromboembolism Associated with Treatment of ITP with Rituximab: Adverse Event Reported in Two Randomized Controlled Trials

Thrombin-Generating Capacity of Microvesicles (MVs) in Patients with Immune Thrombocytopenia (ITP) before and during Treatment with Thrombopoietin-Receptor Agonists (TPO-RA)

Email alerts

ASH Publications

American Society of Hematology

Real-World Use, Effectiveness and Safety of Romiplostim, Eltrombopag and Avatrombopag in Immune Thrombocytopenia: Data from the Norwegian ITP Registry

Validation of Differentially Expressed Micrornas in Primary Immune Thrombocytopenia Suggests Mir-199a-5p Is a Potential Diagnostic Biomarker

Health Related Quality of Life in Patients with Primary ITP Compared with Population Norms: A Multicenter Retrospective Analysis of Data from Norwegian ITP Registry

The Risk of Thromboembolism Associated with Treatment of ITP with Rituximab: Adverse Event Reported in Two Randomized Controlled Trials

Thrombin-Generating Capacity of Microvesicles (MVs) in Patients with Immune Thrombocytopenia (ITP) before and during Treatment with Thrombopoietin-Receptor Agonists (TPO-RA)

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only